Gemcitabine (G) plus cisplatin (C) is a highly active regimen in first-line treatment of metastatic breast cancer (MBC): Results of a multicenter phase II trial

被引：0
作者：
Fuentes, H
Calderillo, G
Alexander, F
Ramirez, M
Avila, E
Perez, L
Aguirre, C
机构：
[1] Inst Nacl Cancerol, SSA, Mexico City, DF, Mexico
[2] Hosp Gen Occidente Seguro Social, SSA, Oncol Serv, Guadalajara, Jalisco, Mexico
[3] IMSS, Unidad Morelos 1, Cuernavaca, Morelos, Mexico
[4] Ctr Med Potosi, Oncol & Radiotherapy Serv, San Luis Potosi, Mexico
[5] Clin ISSSTE, Oncol Serv, Ensenada, Baja California, Mexico
来源：
EUROPEAN JOURNAL OF CANCER | 2002年 / 38卷
关键词：
D O I：
10.1016/S0959-8049(02)80216-7
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
130
引用
收藏
页码：S72 / S72
页数：1
相关论文
共 50 条
[41]   Multicenter Phase II Trial of First-line Docetaxel/Gemcitabine in Advanced Breast Cancer Pretreated with Adjuvant Anthracyclines [J].
Vici, Patrizia ;
Giotta, Francesco ;
Di Lauro, Luigi ;
Brandi, Mario ;
Gebbia, Vittorio ;
Foggi, Paolo ;
Lorusso, Vito ;
Vitucci, Carlo ;
Sergi, Domenico ;
Fattoruso, Silvia Ileana ;
Giannarelli, Diana ;
Viola, Giuditta ;
Corsetti, Serena ;
Colucci, Giuseppe ;
Lopez, Massimo .
ANTICANCER RESEARCH, 2009, 29 (05) :1841-1845
[42]   Phase II trial of first-line capecitabine plus cisplatin in patients with advanced/metastatic nasopharyngeal cancer (NPC) [J].
Chua, D. ;
Ng, W. ;
Yiu, H. ;
Seetalarom, K. ;
Kurnianda, J. ;
Sze, W. ;
Krishnan, G. ;
Shotelersuk, K. ;
Hong, R. ;
Forster, G. .
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
[43]   Capecitabine (X) plus trastuzumab (H) as first-line treatment in patients (pts) with HER2-positive metastatic breast cancer (MBC): phase II trial results. [J].
Xu, L. ;
Song, S. ;
Zhu, J. ;
Luo, R. ;
Li, L. ;
Jiao, S. ;
Pan, H. ;
Tao, M. ;
Su, Y. ;
Liu, D. .
BREAST CANCER RESEARCH AND TREATMENT, 2006, 100 :S102-S102
[44]   Capecitabine (X) in the first-line treatment of metastatic breast cancer (MBC). [J].
Harbeck, N. ;
Kaufmann, M. ;
Siedentopf, F. ;
Dalivoust, P. ;
Debled, M. ;
Robert, N. J. ;
O'Shaughnessy, J. .
JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
[45]   A COMPARISON OF FIRST-LINE TREATMENT WITH GEMCITABINE PLUS DOCETAXEL VERSUS GEMCITABINE PLUS VINORELBINE IN WOMEN WITH METASTATIC BREAST CANCER [J].
Bensalem, A. ;
Bouzid, K. .
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2013, 23 (08)
[46]   Preliminary results of a multicenter phase II trial of vinflunine (with trastuzumab in HER2+pts) as first-line treatment in metastatic breast cancer [J].
Peacock, N. W. ;
Spigel, D. R. ;
Mainwaring, M. G. ;
Thompson, D. S. ;
Simons, L. ;
Rubin, M. S. ;
McCleod, M. ;
Harwin, W. N. ;
Schreiber, F. J. ;
Yardley, D. A. .
JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
[47]   Biweekly gemcitabine-paclitaxel, gemcitabine-carboplatin, or gemcitabine-cisplatin as first-line treatment in metastatic breast cancer after anthracycline failure: a phase II randomized selection trial [J].
Xu, Binghe ;
Jiang, Zefei ;
Kim, Sung-Bae ;
Yu, Shiying ;
Feng, Jifeng ;
Malzyner, Artur ;
del Giglio, Auro ;
Chung, Hyun C. ;
Shen, Li Jun ;
Pen, Daniel Lee Kay .
BREAST CANCER, 2011, 18 (03) :203-212
[48]   Sequential treatment with doxorubicin and docetaxel as first-line chemotherapy in metastatic breast cancer (MBC).: Final results of a Phase II GEICAM study [J].
Alba, E ;
Antón, A ;
Ribelles, N ;
Pérez-Carrión, R ;
López-Vega, J ;
Llanos, M ;
Pelegri, A ;
Florián, J ;
Menéndez, M ;
Godés, M .
EUROPEAN JOURNAL OF CANCER, 2002, 38 :S66-S66
[49]   Phase II Trial with Gemcitabine, Paclitaxel and Bevacizumab for the First Line Treatment of Metastatic Breast Cancer. [J].
Guardino, A. E. ;
Chen, M. ;
Levy, M. ;
Chen, M. .
CANCER RESEARCH, 2009, 69 (24) :853S-853S
[50]   Trastuzumab plus capecitabine and docetaxel as first-line therapy for metastatic breast cancer: Phase II results [J].
Gennatas, C. G. ;
Michalaki, V. ;
Gennatas, S. .
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
12345